| Stem definition | Drug id | CAS RN |
|---|---|---|
| dipeptidyl aminopeptidase-IV inhibitors | 4833 | 911637-19-9 |
| Dose | Unit | Route |
|---|---|---|
| 50 | mg | O |
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| June 27, 2012 | Korean Food and Drug Administration (KFDA) |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | A10BD18 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Combinations of oral blood glucose lowering drugs |
| ATC | A10BH06 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| ATC | A10BH52 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Diabetes mellitus type 2 | indication | 44054006 | DOID:9352 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.86 | Basic |
| pKa2 | 0.44 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 | Enzyme | INHIBITOR | IC50 | 7.80 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
| Dipeptidyl peptidase 9 | Enzyme | IC50 | 4.33 | SCIENTIFIC LITERATURE |
| ID | Source |
|---|---|
| 5DHU18M5D6 | UNII |
| D10502 | KEGG_DRUG |
| C3501981 | UMLSCUI |
| CHEBI:134731 | CHEBI |
| CHEMBL3707235 | ChEMBL_ID |
| 11953153 | PUBCHEM_CID |
| DB12412 | DRUGBANK_ID |
| 9291 | INN_ID |
| C534891 | MESH_SUPPLEMENTAL_RECORD_UI |
None